1. Home
  2. ALGS

as 05-24-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

Aligos Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Founded: 2018 Country:
United States
United States
Employees: N/A City: SOUTH SAN FRANCISCO
Market Cap: 49.9M IPO Year: 2020
Target Price: N/A AVG Volume (30 days): 378.5K
Analyst Decision: N/A Number of Analysts: N/A
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.04 EPS Growth: N/A
52 Week Low/High: $0.54 - $1.22 Next Earning Date: 05-07-2024
Revenue: $13,792,000 Revenue Growth: -1.90%
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

ALGS Daily Stock ML Predictions

Share on Social Networks: